Jobs
-
Regency Therapeutics, a division of Luitpold Pharmaceuticals, and Daiichi-Sankyo, Inc. have announced the launch of Sprix ketorolac tromethamine nasal spray “for the short-term (up to 5 days) management of moderate to moderately severe pain that… Read more . . .
-
A Global Multinational Company headquartered in Italy is seeking an enthusiastic and self-motivated individual who would be interested in working as a Unit Head to manage their Analytical Unit. Reporting to the Drug Product Development… Read more . . .
-
Cambridge Consultants Ltd., Cambridge, UK. Are you a talented, creative, mechanical engineer, with a wealth of experience and the ability to transform ideas into functional designs? We are looking for bright, enthusiastic team players to… Read more . . .
-
Data presented at the 2011 American Thoracic Society (ATS) meeting by Novartis regarding combined indacaterol and tiotropium therapy for COPD demonstrate that the LABA/LAMA combination produced greater improvement in lung function than tiotropium alone. Novartis’s… Read more . . .
-
The COPD Foundation is now making its official journal, COPD: Journal Of Chronic Obstructive Pulmonary Disease, available online in a digital format at www.copdjournal.com. According to publisher Ashley Petrylak, the format allows readers to bookmark… Read more . . .
-
A report by the American Lung Association in California claims that a “car of the future” scenario in which zero emission vehicles replace a large percentage of the existing fleet of cars in the state… Read more . . .
-
GSK and AstraZeneca have announced that the two companies, along with the University of Manchester, are working together to create the Manchester Collaborative Centre for Inflammation Research (MCCIR) to facilitate translational research in inflammatory diseases,… Read more . . .
-
According to reports, Takeda Pharmaceutical is looking to buy Swiss pharma company Nycomed, which manufactures several OINDPs, including the Alvesco ciclesonide MDI and Omnaris ciclesonide nasal spray. Nycomed is also developing a ciclesonide HFA nasal… Read more . . .
-
Five days after its end of review meeting with the FDA on May 4 regarding its Afrezza inhaled insulin, MannKind Corporation held a conference call to update its progress and financial situation. During the call,… Read more . . .
-
Software companies S-Matrix and CI Informatics have announced that they will provide their Fusion Inhaler Testing (FIT) software free of charge to universities in the UK. Any UK university that conducts cascade impaction studies is… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland